Informatie:
Fout:
ID
32675
Beschrijving
Study ID: 106904 Clinical Study ID: CRV106904 Study Title: A Randomized, Open-Label, Single-Dose, Four-Period Cross-Over Study to Determine the Effects of Alcohol on the Pharmacokinetics of Carvedilol CR Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: carvedilol Trade Name: Coreg CR,Coreg Study Indication: Hypertension
Trefwoorden
Versies (1)
- 12-11-18 12-11-18 -
Houder van rechten
GSK group of companies
Geüploaded op
12 november 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
A Cross-Over Study of Alcohol Effect on the Pharmacokinetics of Carvedilol - 106904
Serious Adverse Event Form
- StudyEvent: ODM
Similar models
Serious Adverse Event Form
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Subject Identifier
Item
Subject Identifier
integer
Centre Number
Item
Centre Number
integer
Randomisation Number
Item
Randomisation Number
integer
Did the subject experience a serious adverse event during the study?
Item
boolean
If YES, record details below
Item
If YES, record details below
text
Event
Item
Event
text
Start Date
Item
Start Date
date
Start Time
Item
Start Time
time
CL Item
Recovered/Resolved (1)
CL Item
Recovering/Resolving (2)
CL Item
Not recovered/Not resolved (3)
CL Item
Recovered/Resolved with sequelae (4)
CL Item
Fatal (5)
End Date
Item
End Date
date
End Time
Item
End Time
time
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
CL Item
Not applicable (4)
Item
Action Taken with Investigational Product(s) as a Result of the SAE
text
Code List
Action Taken with Investigational Product(s) as a Result of the SAE
CL Item
Investigational product(s) withdrawn (1)
CL Item
Dose reduced (2)
CL Item
Dose increased (3)
CL Item
Dose not changed (4)
CL Item
Dose interrupted (5)
CL Item
Not applicable (6)
Did the subject withdraw from study as a result of this SAE?
Item
Did the subject withdraw from study as a result of this SAE?
boolean
Is there a reasonable possibility the SAE may have been caused by the investigational product?
Item
Is there a reasonable possibility the SAE may have been caused by the investigational product?
boolean
Specify reasons for considering this a SAE
Item
Specify reasons for considering this a SAE
text
Results in death
Item
Results in death
boolean
Is life-threatening
Item
Is life-threatening
boolean
Requires hospitalisation or prolongation of existing hospitalisation
Item
Requires hospitalisation or prolongation of existing hospitalisation
boolean
Results in disability/incapacity
Item
Results in disability/incapacity
boolean
Congenital anomaly/birth defect
Item
Congenital anomaly/birth defect
boolean
Other, specify
Item
Other, specify
text
Date of Birth
Item
Date of Birth
date
CL Item
Male (1)
CL Item
Female (2)
Weight
Item
Weight
float
Item
If Investigational Product(s) was stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were administered?
text
Code List
If Investigational Product(s) was stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were administered?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown at this time (3)
CL Item
Not applicable (4)
Item
Possible Causes other than Investgational Product
integer
Code List
Possible Causes other than Investgational Product
CL Item
Disease under study (1)
CL Item
Medical condition(s) (2)
CL Item
Lack of efficacy (3)
CL Item
Withdrawal of investigational product(s) (4)
CL Item
Concomitant medication(s) (record details in Section 8 below) (5)
CL Item
Activity related to study participation (e.g., procedures) (6)
CL Item
Other (7)
If MEDICAL CONDITIONS, specify
Item
If MEDICAL CONDITIONS, specify
text
If OTHER, specify
Item
If OTHER, specify
text
Relevant past or current medical conditions
Item
Relevant past or current medical conditions
text
Date of Onset
Item
Date of Onset
date
Condition present at Time of the SAE
Item
Condition present at Time of the SAE
boolean
If NO, Date of Last Occurrence
Item
If NO, Date of Last Occurrence
date
Record other relevant risk factors (provide any family or social history (e.g., smoking, alcohol, diet, drug abuse, occupational hazard) relevant to the SAE)
Item
Record other relevant risk factors (provide any family or social history (e.g., smoking, alcohol, diet, drug abuse, occupational hazard) relevant to the SAE)
text
Item Group
Section 8 - Relevant Concomitant Medications
Drug Name
Item
Drug Name
text
Dose
Item
Dose
float
Unit
Item
Unit
text
Frequency
Item
Frequency
text
Route
Item
Route
text
Taken Prior to Study
Item
Taken Prior to Study
boolean
Start Date
Item
Start Date
date
Stop Date
Item
Stop Date
date
Ongoing Medication
Item
Ongoing Medication
boolean
Reason for Medication
Item
Reason for Medication
text
Record details of investigational product
Item
Record details of investigational product
text
Provide details of any other tests/procedures which were carried out to diagnose or confirm the SAE
Item
Provide details of any other tests/procedures which were carried out to diagnose or confirm the SAE
text
Provide a brief narrative description of the SAE and details of treatment given
Item
Provide a brief narrative description of the SAE and details of treatment given
text
Investigator's signature
Item
Investigator's signature
text
Investigator's name (print)
Item
Investigator's name (print)
text
Date
Item
Date
date
Geen commentaren